Alerts will be sent to your verified email
Verify Email
ASTRAZEN
|
Astrazeneca Pharma I
|
Wockhardt
|
Pfizer
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
17.42 % | -3.51 % | 19.03 % |
|
5yr Avg Net Profit Margin
|
9.65 % | -4.28 % | 26.04 % |
|
Price to Book
|
28.4 | 5.29 | 5.57 |
|
P/E
|
119.32 | 0.0 | 29.06 |
|
5yr Avg Cash Conversion Cycle
|
-6.33 Days | -94.15 Days | 21.86 Days |
|
5yr Average Interest Coverage Ratio
|
142.38 | -0.43 | 185.18 |
|
5yr Avg ROCE
|
23.84 % | -0.28 % | 23.84 % |
|
5yr Avg Operating Profit Margin
|
14.57 % | 5.03 % | 31.72 % |
|
5 yr average Debt to Equity
|
0.0 | 0.56 | 0.0 |
|
5yr CAGR Net Profit
|
4.4 % | n/a | 76.68 % |
|
5yr Average Return on Assets
|
8.92 % | -1.79 % | 15.25 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
75.0 % | 49.09 % | 63.92 % |
|
Share Pledged by Promoters
|
0.0 | 15.64 % | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | -16.66 % | 0.0 |
|
Change in Mutual Fund Holding (3 Yrs)
|
3.26 % | 7.99 % | 4.53 % |
|
Astrazeneca Pharma I
|
Wockhardt
|
Pfizer
|
|---|